These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 21470892)

  • 1. [Proteomics and transfusion medicine].
    Lion N; Prudent M; Crettaz D; Tissot JD
    Transfus Clin Biol; 2011 Apr; 18(2):79-96. PubMed ID: 21470892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteomic applications in blood transfusion: working the jigsaw puzzle.
    Devine DV; Schubert P
    Vox Sang; 2011 Jan; 100(1):84-91. PubMed ID: 21175658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteomics and transfusion medicine: future perspectives.
    Queloz PA; Thadikkaran L; Crettaz D; Rossier JS; Barelli S; Tissot JD
    Proteomics; 2006 Oct; 6(20):5605-14. PubMed ID: 16972297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Consistency of a two clinical site sample collection: a proteomics study.
    Wiesner C; Hannum C; Reckamp K; Figlin R; Dubridge R; Roy SM; Lin S; Becker CH; Jones T; Hiller J; Cheville JC; Wilson K
    Proteomics Clin Appl; 2010 Sep; 4(8-9):726-38. PubMed ID: 21137090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microparticles in stored red blood cells: an approach using flow cytometry and proteomic tools.
    Rubin O; Crettaz D; Canellini G; Tissot JD; Lion N
    Vox Sang; 2008 Nov; 95(4):288-97. PubMed ID: 19138258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteomic analysis of malignant B-cell derived microparticles reveals CD148 as a potentially useful antigenic biomarker for mantle cell lymphoma diagnosis.
    Miguet L; Béchade G; Fornecker L; Zink E; Felden C; Gervais C; Herbrecht R; Van Dorsselaer A; Mauvieux L; Sanglier-Cianferani S
    J Proteome Res; 2009 Jul; 8(7):3346-54. PubMed ID: 19413345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HUPO Plasma Proteome Project specimen collection and handling: towards the standardization of parameters for plasma proteome samples.
    Rai AJ; Gelfand CA; Haywood BC; Warunek DJ; Yi J; Schuchard MD; Mehigh RJ; Cockrill SL; Scott GB; Tammen H; Schulz-Knappe P; Speicher DW; Vitzthum F; Haab BB; Siest G; Chan DW
    Proteomics; 2005 Aug; 5(13):3262-77. PubMed ID: 16052621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peptidomic analysis of human blood specimens: comparison between plasma specimens and serum by differential peptide display.
    Tammen H; Schulte I; Hess R; Menzel C; Kellmann M; Mohring T; Schulz-Knappe P
    Proteomics; 2005 Aug; 5(13):3414-22. PubMed ID: 16038021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteomics: applications relevant to transfusion medicine.
    Page MJ; Griffiths TA; Bleackley MR; MacGillivray RT
    Transfus Med Rev; 2006 Jan; 20(1):63-74. PubMed ID: 16373189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioinformatics challenges in the proteomic analysis of human plasma.
    Foster JM; Martens L
    Methods Mol Biol; 2011; 728():333-47. PubMed ID: 21468959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteomics applied to transfusion plasma: the beginning of the story.
    Ortiz A; Richa L; Defer C; Dernis D; Huart JJ; Tokarski C; Rolando C
    Vox Sang; 2013 May; 104(4):275-91. PubMed ID: 23438183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rarity gives a charm: evaluation of trace proteins in plasma and serum.
    Lathrop JT; Hayes TK; Carrick K; Hammond DJ
    Expert Rev Proteomics; 2005 Jun; 2(3):393-406. PubMed ID: 16000085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteomics of blood and derived products: what's next?
    Prudent M; Tissot JD; Lion N
    Expert Rev Proteomics; 2011 Dec; 8(6):717-37. PubMed ID: 22087657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversed-phase high-performance liquid chromatographic prefractionation of immunodepleted human serum proteins to enhance mass spectrometry identification of lower-abundant proteins.
    Martosella J; Zolotarjova N; Liu H; Nicol G; Boyes BE
    J Proteome Res; 2005; 4(5):1522-37. PubMed ID: 16212403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Profiling of myelin proteins by 2D-gel electrophoresis and multidimensional liquid chromatography coupled to MALDI TOF-TOF mass spectrometry.
    Vanrobaeys F; Van Coster R; Dhondt G; Devreese B; Van Beeumen J
    J Proteome Res; 2005; 4(6):2283-93. PubMed ID: 16335977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Red blood cell proteomics.
    Pasini EM; Mann M; Thomas AW
    Transfus Clin Biol; 2010 Sep; 17(3):151-64. PubMed ID: 20655788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Applying proteomics technology to platelet research.
    García A; Watson SP; Dwek RA; Zitzmann N
    Mass Spectrom Rev; 2005; 24(6):918-30. PubMed ID: 15599945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum proteomic approach for the identification of serum biomarkers contributed by oral squamous cell carcinoma and host tissue microenvironment.
    Bijian K; Mlynarek AM; Balys RL; Jie S; Xu Y; Hier MP; Black MJ; Di Falco MR; LaBoissiere S; Alaoui-Jamali MA
    J Proteome Res; 2009 May; 8(5):2173-85. PubMed ID: 19284786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trans-proteomic pipeline: a pipeline for proteomic analysis.
    Pedrioli PG
    Methods Mol Biol; 2010; 604():213-38. PubMed ID: 20013374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent advances in clinical proteomics using mass spectrometry.
    Dowling P; Meleady P; Henry M; Clynes M
    Bioanalysis; 2010 Sep; 2(9):1609-15. PubMed ID: 21083289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.